Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Manuela Neumann(Institute on Aging), Deepak M. Sampathu(Institute on Aging), Linda K. Kwong(Institute on Aging), Adam C. Truax(Institute on Aging), Matthew C. Micsenyi(Institute on Aging), Thomas T. Chou(Institute on Aging), Jennifer Bruce(Institute on Aging), Theresa Schuck(Institute on Aging), Murray Grossman(Institute on Aging), Christopher M. Clark(Institute on Aging), Leo McCluskey(Institute on Aging), Bruce L. Miller(Institute on Aging), Eliezer Masliah(Institute on Aging), Ian R. Mackenzie(Institute on Aging), Howard Feldman(Institute on Aging), W. Feiden(Institute on Aging), Hans A. Kretzschmar(Institute on Aging), John Q. Trojanowski(Institute on Aging), Virginia M.‐Y. Lee(Institute on Aging)
Cited by 6,581
Abstract
Ubiquitin-positive, tau- and alpha-synuclein-negative inclusions are hallmarks of frontotemporal lobar degeneration with ubiquitin-positive inclusions and amyotrophic lateral sclerosis. Although the identity of the ubiquitinated protein specific to either disorder was unknown, we showed that TDP-43 is the major disease protein in both disorders. Pathologic TDP-43 was hyper-phosphorylated, ubiquitinated, and cleaved to generate C-terminal fragments and was recovered only from affected central nervous system regions, including hippocampus, neocortex, and spinal cord. TDP-43 represents the common pathologic substrate linking these neurodegenerative disorders.
Related Papers
No related papers found
Powered by citation graph analysis